DD254202A5 - Verfahren zur herstellung von thiazole(4,5-c)chinolin-derivaten - Google Patents

Verfahren zur herstellung von thiazole(4,5-c)chinolin-derivaten Download PDF

Info

Publication number
DD254202A5
DD254202A5 DD86296208A DD29620886A DD254202A5 DD 254202 A5 DD254202 A5 DD 254202A5 DD 86296208 A DD86296208 A DD 86296208A DD 29620886 A DD29620886 A DD 29620886A DD 254202 A5 DD254202 A5 DD 254202A5
Authority
DD
German Democratic Republic
Prior art keywords
general formula
quinoline
acid
reaction
acid addition
Prior art date
Application number
DD86296208A
Other languages
German (de)
English (en)
Inventor
Knoll
Berenyi
Budai
Fuerts
Timbr
Zsila
Niklya
Petocz
Mandi
Original Assignee
������@������������k��
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ������@������������k�� filed Critical ������@������������k��
Publication of DD254202A5 publication Critical patent/DD254202A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DD86296208A 1985-11-12 1986-11-12 Verfahren zur herstellung von thiazole(4,5-c)chinolin-derivaten DD254202A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU854304A HU197019B (en) 1985-11-12 1985-11-12 Process for producing thiqzolo (4,5-c) quinoline derivatives and pharmaceuticals comprising same

Publications (1)

Publication Number Publication Date
DD254202A5 true DD254202A5 (de) 1988-02-17

Family

ID=10967593

Family Applications (1)

Application Number Title Priority Date Filing Date
DD86296208A DD254202A5 (de) 1985-11-12 1986-11-12 Verfahren zur herstellung von thiazole(4,5-c)chinolin-derivaten

Country Status (24)

Country Link
US (1) US4904669A (hu)
JP (1) JPS62161792A (hu)
CN (1) CN86107754A (hu)
AU (1) AU592384B2 (hu)
BE (1) BE905719A (hu)
BG (1) BG46156A3 (hu)
CH (1) CH670829A5 (hu)
DD (1) DD254202A5 (hu)
DE (1) DE3638563A1 (hu)
DK (1) DK539786A (hu)
ES (1) ES2002543A6 (hu)
FI (1) FI864611A (hu)
FR (1) FR2603588A1 (hu)
GB (1) GB2184117B (hu)
HU (1) HU197019B (hu)
IL (1) IL80611A0 (hu)
IT (1) IT1213379B (hu)
NL (1) NL8602878A (hu)
NO (1) NO864518L (hu)
PL (1) PL148186B1 (hu)
SE (1) SE8604839L (hu)
SU (1) SU1544190A3 (hu)
YU (1) YU192186A (hu)
ZA (1) ZA868583B (hu)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU199423B (en) * 1987-04-24 1990-02-28 Egyt Gyogyszervegyeszeti Gyar Process for producing 3-amino-4-/ethylthio/-quinoline and pharmaceutical compositions comprising such compounds
US6110929A (en) * 1998-07-28 2000-08-29 3M Innovative Properties Company Oxazolo, thiazolo and selenazolo [4,5-c]-quinolin-4-amines and analogs thereof
US6677347B2 (en) * 2000-12-08 2004-01-13 3M Innovative Properties Company Sulfonamido ether substituted imidazoquinolines
US20040214851A1 (en) * 2003-04-28 2004-10-28 3M Innovative Properties Company Compositions and methods for induction of opioid receptors
BRPI0412902A (pt) * 2003-08-12 2006-09-26 3M Innovative Properties Co compostos contendo imidazo substituìdo por oxima
CA2536136C (en) * 2003-08-27 2012-10-30 3M Innovative Properties Company Aryloxy and arylalkyleneoxy substituted imidazoquinolines
AU2004270201A1 (en) * 2003-09-05 2005-03-17 3M Innovative Properties Company Treatment for CD5+ B cell lymphoma
CA2540541C (en) * 2003-10-03 2012-03-27 3M Innovative Properties Company Alkoxy substituted imidazoquinolines
US20090075980A1 (en) * 2003-10-03 2009-03-19 Coley Pharmaceutical Group, Inc. Pyrazolopyridines and Analogs Thereof
US7544697B2 (en) * 2003-10-03 2009-06-09 Coley Pharmaceutical Group, Inc. Pyrazolopyridines and analogs thereof
WO2005048933A2 (en) 2003-11-14 2005-06-02 3M Innovative Properties Company Oxime substituted imidazo ring compounds
US8598192B2 (en) * 2003-11-14 2013-12-03 3M Innovative Properties Company Hydroxylamine substituted imidazoquinolines
AU2004293078B2 (en) * 2003-11-25 2012-01-19 3M Innovative Properties Company Substituted imidazo ring systems and methods
EP1701955A1 (en) * 2003-12-29 2006-09-20 3M Innovative Properties Company Arylalkenyl and arylalkynyl substituted imidazoquinolines
WO2005066169A2 (en) * 2003-12-30 2005-07-21 3M Innovative Properties Company Imidazoquinolinyl, imidazopyridinyl, and imidazonaphthyridinyl sulfonamides
CA2559863A1 (en) * 2004-03-24 2005-10-13 3M Innovative Properties Company Amide substituted imidazopyridines, imidazoquinolines, and imidazonaphthyridines
WO2005123080A2 (en) * 2004-06-15 2005-12-29 3M Innovative Properties Company Nitrogen-containing heterocyclyl substituted imidazoquinolines and imidazonaphthyridines
WO2006038923A2 (en) * 2004-06-18 2006-04-13 3M Innovative Properties Company Aryl substituted imidazonaphthyridines
WO2006009832A1 (en) * 2004-06-18 2006-01-26 3M Innovative Properties Company Substituted imidazo ring systems and methods
US7915281B2 (en) * 2004-06-18 2011-03-29 3M Innovative Properties Company Isoxazole, dihydroisoxazole, and oxadiazole substituted imidazo ring compounds and method
US8026366B2 (en) * 2004-06-18 2011-09-27 3M Innovative Properties Company Aryloxy and arylalkyleneoxy substituted thiazoloquinolines and thiazolonaphthyridines
WO2006026760A2 (en) * 2004-09-02 2006-03-09 3M Innovative Properties Company 1-amino imidazo-containing compounds and methods
WO2006063072A2 (en) * 2004-12-08 2006-06-15 3M Innovative Properties Company Immunomodulatory compositions, combinations and methods
US7943609B2 (en) * 2004-12-30 2011-05-17 3M Innovative Proprerties Company Chiral fused [1,2]imidazo[4,5-C] ring compounds
ES2392648T3 (es) 2004-12-30 2012-12-12 3M Innovative Properties Company Compuestos quirales sustituidos que contienen un núcleo 1,2-imidazo-4,5-c condensado
US9248127B2 (en) * 2005-02-04 2016-02-02 3M Innovative Properties Company Aqueous gel formulations containing immune response modifiers
WO2007120121A2 (en) * 2005-02-09 2007-10-25 Coley Pharmaceutical Group, Inc. Oxime and hydroxylamine substituted thiazolo[4,5-c] ring compounds and methods
EP1846405A2 (en) 2005-02-11 2007-10-24 3M Innovative Properties Company Oxime and hydroxylamine substituted imidazo 4,5-c ring compounds and methods
AU2006232377A1 (en) 2005-04-01 2006-10-12 Coley Pharmaceutical Group, Inc. Pyrazolopyridine-1,4-diamines and analogs thereof
CA2602590A1 (en) 2005-04-01 2006-10-12 Coley Pharmaceutical Group, Inc. 1-substituted pyrazolo (3,4-c) ring compounds as modulators of cytokine biosynthesis for the treatment of viral infections and neoplastic diseases
WO2008008432A2 (en) * 2006-07-12 2008-01-17 Coley Pharmaceutical Group, Inc. Substituted chiral fused( 1,2) imidazo (4,5-c) ring compounds and methods
KR20210082473A (ko) 2018-10-23 2021-07-05 바스프 에스이 트리시클릭 살충 화합물
WO2021209265A1 (en) 2020-04-14 2021-10-21 Basf Se Tricyclic pesticidal compounds

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2024207A (en) * 1978-05-26 1980-01-09 Lepetit Spa New tricyclic ortho-fused heterocyclic compounds
HU196308B (en) * 1985-11-12 1988-11-28 Egyt Gyogyszervegyeszeti Gyar Process for producing pharmaceutical compositions containing 2-methyl-thiazolo/4,5-c/quinoline as active component

Also Published As

Publication number Publication date
ES2002543A6 (es) 1988-08-16
US4904669A (en) 1990-02-27
CN86107754A (zh) 1987-08-05
SE8604839L (sv) 1987-05-13
YU192186A (en) 1988-10-31
JPS62161792A (ja) 1987-07-17
HUT44260A (en) 1988-02-29
FI864611A0 (fi) 1986-11-12
IT1213379B (it) 1989-12-20
NO864518L (no) 1987-05-13
SE8604839D0 (sv) 1986-11-12
FR2603588A1 (fr) 1988-03-11
NL8602878A (nl) 1987-06-01
GB8627043D0 (en) 1986-12-10
BE905719A (fr) 1987-05-07
IT8622312A0 (it) 1986-11-12
DK539786D0 (da) 1986-11-12
ZA868583B (en) 1987-08-26
SU1544190A3 (ru) 1990-02-15
NO864518D0 (no) 1986-11-12
DE3638563A1 (de) 1987-06-25
AU6508986A (en) 1987-05-14
FI864611A (fi) 1987-05-13
BG46156A3 (en) 1989-10-16
PL148186B1 (en) 1989-09-30
GB2184117B (en) 1989-10-11
HU197019B (en) 1989-02-28
DK539786A (da) 1987-05-13
IL80611A0 (en) 1987-02-27
GB2184117A (en) 1987-06-17
PL262346A1 (en) 1988-03-03
AU592384B2 (en) 1990-01-11
CH670829A5 (hu) 1989-07-14

Similar Documents

Publication Publication Date Title
DD254202A5 (de) Verfahren zur herstellung von thiazole(4,5-c)chinolin-derivaten
DE3026201C2 (hu)
EP0127763B1 (de) Tricyclische Ether, Verfahren zu ihrer Herstellung, ihre Anwendung und sie enthaltende Arzneimittel
DD216929A5 (de) Verfahren zur herstellung von thiazolidinderivaten
AT399338B (de) Neue substituierte benzamide, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen, die diese benzamide enthalten
DD158240A5 (de) Verfahren zur herstellung von imidodisulfamiden
EP0133530B1 (de) 1,6-Naphthyridinon-Derivate, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
DE2900644A1 (de) 8 beta -alkyl-substituierte morphian- 6-on verbindungen, verfahren zu deren herstellung, sowie deren verwendung als pharmazeutisches mittel
EP0105210B1 (de) Isochinolinderivate, Verfahren zu ihrer Herstellung, pharmazeutische Präparate auf Basis dieser Verbindungen und ihre Verwendung
DE2841126C2 (hu)
DE2251559C2 (de) 5,6-Dihydro-pyrrolo[3,4-b]pyridinderivate, Verfahren zu ihrer Herstellung und pharmazeutische Zusammensetzungen
DE2301069C2 (de) Neue Isoindolinonderivate, ihre Herstellung und diese enthaltende pharmazeutische Mittel
CH669729A5 (hu)
DE2802453B2 (de) Derivate des 3-[(3-Alkyl-5-isochinolyl)-imino]-1,5,10,10a-tetrahydro-thiazolo [3,4-b] zu isochinolins, ihre Herstellung und die sie enthaltenden Zusammensetzungen
EP0177907A1 (de) Neue 2-Pyridin-thiol-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Präparate
DE2207430C3 (de) 1,2,4,5-Tetrahydro-3H-3-benzazepin, ein Verfahren zu ihrer Herstellung und diese enthaltendes pharmazeutisches Mittel
DE1695812B2 (de) Dibenzo [cfl -1,2-thiazepin-derivate, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zubereitung
DE2900918A1 (de) 8 beta -aethyl- und 8 beta -methyl-4,5 - epoxymorphinan-6-on-verbindungen
DE2943286C2 (hu)
DD242406A5 (de) 4-oxo-pyrido (2,3-d) pyrimidin-derivate, verfahren zu deren herstellung und diese enthaltende arzneimittel
CH641800A5 (de) Pyrido-pyrimidine, verfahren zu ihrer herstellung und die diese verbindungen enthaltenden arzneimittel.
AT394553B (de) Neue chinolinthioaether
DE2034588B2 (de) ej-Dimethoxy^-benzylisochinoline, Verfahren zu ihrer Herstellung und Arzneimittel
EP0174459A1 (de) 9- beziehungsweise 11-(Nitro)-apovincaminsäurederivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE2500692C3 (de) Derivate des 4-Amidoalkylen-4'oxy diphenyle

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee